Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients

BACKGROUND: Luteinizing hormone-releasing hormone (LH-RH) agonists are the standard for androgen deprivation therapy (ADT) in prostate cancer (PCa) patients. Current guidelines recommend serum testosterone measurement to assess the efficacy of ADT and to define castration resistance. However, serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Morote, Juan, Comas, Imma, Ferrer, Roser, Planas, Jacques, Celma, Anna, Regis, Lucas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651562/
https://www.ncbi.nlm.nih.gov/pubmed/29058606
http://dx.doi.org/10.1186/s12929-017-0386-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651562/
https://www.ncbi.nlm.nih.gov/pubmed/29058606
http://dx.doi.org/10.1186/s12929-017-0386-0

Ejemplares similares